| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D271-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate |
2004-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d035ff9eb2c5112372f69ffb898ba1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_235f445e28b2a6b04168d81f3fae3a32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88dad869b69bf775edcfafa116ce46b7 |
| publicationDate |
2017-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0408767-B1 |
| titleOfInvention |
NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF HIV-MEDIATED DISEASES, THEIR USE, AND PHARMACEUTICAL COMPOSITION |
| abstract |
"non-nucleoside reverse transcriptase inhibitors i for the treatment of hiv-mediated diseases". The present invention relates to novel heterocyclic compounds of formula (I), wherein R1-R1-R4, X1-R1 and X-R2 are as defined in the summary and pharmaceutically acceptable salts and solvates thereof. to inhibit or modulate human immunodeficiency virus (hiv) reverse transcriptase with compounds of formula (i), pharmaceutical compositions containing formula i mixed with at least one solvent, vehicle or excipient, and processes for preparing the compounds of formula i. The compounds are useful for treating disorders in which HIV and genetically related viruses are involved. |
| priorityDate |
2003-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |